MIRA INFORM REPORT

 

 

Report Date :

13.02.2014

 

IDENTIFICATION DETAILS

 

Name :

BIOGENA (API) LIMITED

 

 

Registered Office :

10A Gennadiou , 2nd Floor , Apt 201, Limassol

 

 

Country :

Cyprus

 

 

Date of Incorporation :

29.12.1983

 

 

Com. Reg. No.:

C21046

 

 

Legal Form :

Limited Company

 

 

Line of Business :

·         Manufacture of basic pharmaceutical products

·         Manufacture of chemically pure sugars - processing of glands and manufacture of extracts of glands

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

Payment Behaviour :

Unknown

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2013

 

Country Name

Previous Rating

(30.06.2013)

Current Rating

(30.09.2013)

Cyprus

B2

C1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

CYPRUS - ECONOMIC OVERVIEW

 

The area of the Republic of Cyprus under government control has a market economy dominated by the service sector, which accounts for four-fifths of GDP. Tourism, financial services, and real estate are the most important sectors. Erratic growth rates over the past decade reflect the economy's reliance on tourism, the profitability of which can fluctuate with political instability in the region and economic conditions in Western Europe. Nevertheless, the economy in the area under government control has grown at a rate well above the EU average since 2000. Cyprus joined the European Exchange Rate Mechanism (ERM2) in May 2005 and adopted the euro as its national currency on 1 January 2008. An aggressive austerity program in the preceding years, aimed at paving the way for the euro, helped turn a soaring fiscal deficit (6.3% in 2003) into a surplus of 1.2% in 2008, and reduced inflation to 4.7%. This prosperity came under pressure in 2009, as construction and tourism slowed in the face of reduced foreign demand triggered by the ongoing global financial crisis. Although Cyprus lagged behind its EU peers in showing signs of stress from the global crisis, the economy tipped into recession in 2009, contracting by 1.7%, and has been slow to bounce back since, posting anemic growth in 2010-11 before contracting again by 2.3% in 2012. Serious problems surfaced in the Cypriot financial sector in early 2011 as the Greek fiscal crisis and euro zone debt crisis deepened. Cyprus's borrowing costs have risen steadily because of its exposure to Greek debt. Two of Cyprus's biggest banks are among the largest holders of Greek bonds in Europe and have a substantial presence in Greece through bank branches and subsidiaries. Cyprus experienced numerous downgrades of its credit rating in 2012 and has been cut off from international money markets. The Cypriot economy contracted in 2012 following the writedown of Greek bonds. A liquidity squeeze is choking the financial sector and the real economy as many global investors are uncertain the Cypriot economy can weather the EU crisis. The budget deficit rose to 7.4% of GDP in 2011, a violation of the EU's budget deficit criteria - no more than 3% of GDP. In response to the country's deteriorating finances and serious risk of contagion from the Greek debt crisis, Nicosia implemented measures to cut the cost of the state payroll, curb tax evasion, and revamp social benefits, and trimmed the deficit to 4.2% of GDP in 2012. In July, Nicosia became the fifth euro zone government to request an economic bailout program from the European Commission, the European Central Bank, and the International Monetary Fund - known collectively as the "Troika". Negotiations over the final details of the plan are ongoing.

 

Source : CIA

 


Basic Information

 

Registered Name

BIOGENA (API) LIMITED

 

English Name

BIOGENA (API) LIMITED

Registered Address

10A Gennadiou , 2nd Floor , Apt 201, Limassol, Cyprus

Headquarters:

1 Iliou, Ypsonas Industrial Area, Limassol, 3056, PoBox 50170, Cyprus

Telephone

+35725561310

Fax

+35725562253

E-mail

elena.louca@medochemie.com , office@biogena-api.com

Web Site

Non Retrievable

Legal Type

Limited Company

Status

Registered and operational

Registration No

C21046

Registration Date

29/12/1983

Start Date

29/12/1983

Years of Operation:

31

Last annual report

30/12/2003

Tax Reg No:

VAT: CY10021046S

Last return

19/10/2010

 

 

 

 

Summary

 

Employees

February 2014

 

 

 

Company

 

 

 

 

 

Total Number

Not Available

 

 

 

 

 

 

Additional Info:

Legal Advisor and Correspondent: STELIOS K. STYLIANIDIS LLC, 8A G Gennadiou, 1st Floor, Apt 3, P.O. Box: 53114, 3300, Limassol -Tel 25828900

 

 

 

Payment

 

 

Payment Habits:

No complaints

A check against all available information sources revealed that no late payment incidents against Subject Company exist.

 

Financial strength

Unable to comment

Given the fact that no recent detailed financial statements were released to us, we feel unable to express a safe and reliable opinion on the creditability and Financial Strength.

 

 

Business History

 

Date

Event Name

Old Value

New Value

15/01/2006

Authorized Capital Increased

500000.00 CYP

10000000.00 CYP

05/01/2000

Change of name

BIOGENA LIMITED

BIOGENA (API) LIMITED

 

 

Previous Locations

           

Registered

From:

To:

8A, Georgiou Gennadiou, 1st Foor, Apt. 3, Limassol, Cyprus

29/12/1983

08/12/1993

 

 

 

Capital

 

Authorized Capital

1,710,000.00

EUR

Issued Capital

1,608,030.99

EUR

Nominal No Of Shares

1,000,000.00

 

Issued No Of Shares

940,369.00

 

Nominal value

1.71

EUR

Paid Up

1,608,030.99

EUR

 

 

Corporate Structure

 

 

Directors

Position

Acts As

ID

Occupation

Age

Appointed

Other dir.

 

 

 

TSIATINIS PANAGIOTIS

 

Director

 

550345(ID)

Pharmasist

56

21/06/1994

No

 

28 Lekormpouzie, Galanos House, Apt. 24, Limassol, 3075, Cyprus

 

Other Directorship:

 

No Information Found

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

 

 

 

 

 

 

 

DIOGENOUS PITTA DAPHNI

 

Director

 

747372(ID)

Pharmasist

42

04/03/1999

Yes

 

43 Ellados, Limassol, 3041, Cyprus

 

Other Directorship:

 

 

 

Name

 

Registration Date

Reg. No.

Status

Position

Update Date

 

MEDOCHEMIE LIMITED

 

11/02/1976

C7761

Registered and operational

Director

27/07/2012

 

DELFIS EPENDYSEIS LIMITED

 

13/12/2007

C215757

Registered and operational

Director

10/02/2011

 

K.I.D. PROPERTIES LIMITED

 

11/01/2000

C108145

Registered and operational

Director

21/09/2010

 

 

 

Other Shareholding:

 

 

 

Name

 

Registration Date

Reg. No.

Status

%

Update Date

 

K.I.D. PROPERTIES LIMITED

 

11/01/2000

C108145

Registered and operational

33.33333

29/09/2009

 

DELFIS EPENDYSEIS LIMITED

 

13/12/2007

C215757

Registered and operational

33

10/02/2011

 

EVESTOR HOLDINGS LIMITED

 

09/08/1999

C104081

Registered and operational

0.1

03/02/2009

 

MEDOCHEMIE LIMITED

 

11/02/1976

C7761

Registered and operational

0

27/07/2012

 

 

 

 

Secretary

Position

Acts As

ID

Occupation

Age

Appointed

Other dir.

 

STYLIANIDES K. STELIOS

 

Company Secretary

 

154262(ID)

Lawyer

71

29/12/1983

No

1A Achnas, Limassol, 3076, Cyprus

 

Other Directorship:

 

 

 

Name

 

Registration Date

Reg. No.

Status

Position

Update Date

 

STELIOS STYLIANIDES CORPORAID LIMITED

 

18/08/2007

C205818

Registered - start the procedure of erasing (section 327)

Director

26/10/2009

 

Other Shareholding:

 

 

Name

 

Registration Date

Reg. No.

Status

%

Update Date

 

BIOPHARM RESEARCH INSTITUTE LIMITED

 

28/12/1983

C21043

Registered and operational

50

30/09/2009

 

STELIOS STYLIANIDES CORPORAID LIMITED

 

18/08/2007

C205818

Registered - start the procedure of erasing (section 327)

25

26/10/2009

 

T.G.S. PROJECTS LIMITED

 

13/01/1997

C83595

Registered and operational

0.1

26/01/2009

 

CRATAEGUS LIMITED

 

20/02/1975

C7106

Registered and operational

0.02

16/09/2009

 

 

 

Shareholders

ID / Reg. No.

Acts As

Nationality

Shares

%

Shares Breakdown

Class

Type

 

DIOGENOUS PITTA DAPHNI

 

747372(ID)

 

CYPRIOT

766400

81.49992

-

-

-

 

43 Ellados, Limassol, 3041, Cyprus

 

Other Directorship:

 

 

Name

 

Registration Date

Reg. No.

Status

Position

Update Date

 

MEDOCHEMIE LIMITED

 

11/02/1976

C7761

Registered and operational

Director

27/07/2012

 

DELFIS EPENDYSEIS LIMITED

 

13/12/2007

C215757

Registered and operational

Director

10/02/2011

 

K.I.D. PROPERTIES LIMITED

 

11/01/2000

C108145

Registered and operational

Director

21/09/2010

 

 

 

Other Shareholding:

 

 

 

Name

 

Registration Date

Reg. No.

Status

%

Update Date

 

K.I.D. PROPERTIES LIMITED

 

11/01/2000

C108145

Registered and operational

33.33333

29/09/2009

 

DELFIS EPENDYSEIS LIMITED

 

13/12/2007

C215757

Registered and operational

33

10/02/2011

 

EVESTOR HOLDINGS LIMITED

 

09/08/1999

C104081

Registered and operational

0.1

03/02/2009

 

MEDOCHEMIE LIMITED

 

11/02/1976

C7761

Registered and operational

0

27/07/2012

 

COFIRCONT - COMPAGNIA FIDUCIARIA S.P.A.

 

02589350152

 

-

84634

9.00008

-

-

-

 

10/A, Via Sant' Andrea, Milano, 20121, Italy

Other Directorship:

 

No Information Found

 

 

 

Other Shareholding:

 

 

 

Name

 

Registration Date

Reg. No.

Status

%

Update Date

 

ANDI - VENTIS LIMITED

 

03/03/2000

C109522

Registered and operational

25

19/09/2012

 

 

MIAT S.P.A.

 

02796480156

 

-

56422

5.99999

-

-

-

 

20 Via Menabrea, Milano, 20159, Italy

Other Directorship:

 

No Information Found

 

 

 

Other Shareholding:

 

No Information Found

 

 

SIANIOU LENA

 

653035(ID)

 

CYPRIOT

32913

3.50001

-

-

-

 

30 Ploutarchou, Limassol, 3060, Cyprus

Other Directorship:

 

 

 

Name

 

Registration Date

Reg. No.

Status

Position

Update Date

 

BIOPHARM RESEARCH INSTITUTE LIMITED

 

28/12/1983

C21043

Registered and operational

Director

07/07/2011

 

DOROTHEA DEVELOPMENTS LIMITED

 

31/05/1994

C62539

Registered and operational

Director

10/03/2010

 

 

 

Other Shareholding:

 

No Information Found

 

 

 

Operation

 

 

 

Activity Code

Description

NACE 2.1

2110

Manufacture of basic pharmaceutical products - This class includes: - manufacture of medicinal active substances to be used for their pharmacological properties in the manufacture of medicaments: antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids etc. - processing of blood - This class also includes: - manufacture of chemically pure sugars - processing of glands and manufacture of extracts of glands

 

 

 

 

 

 

 

 

 

 

 

Line of Business

The company in question was established in order to get involved with the trade of chemicals and pharmaceutical products such as detergents, soaps etc.

 

 

 

 

 

 

 

 

 

Export to

Percentage

 

Comments

Non Retrievable

 

 

 

 

 

 

 

 

 

 

 

 

Import from

Percentage

 

Comments

Non Retrievable

 

 

 

 

 

 

 

 

 

 

 

 

Premises

 

 

 

 

 

 

Type

Headquarters

 

 

 

Address:

1 Iliou, Ypsonas Industrial Area, Limassol, 3056, PoBox 50170, Cyprus

 

Headquarters comprise of

Offices

 

 

 

 

 

 

 

 

 

 

Affiliates and Subsidiaries

Relation

Year Reg.

 

MEDOCHEMIE LIMITED

Affiliated Company

 

 

 

 

 

 

Charges

 

 

No

Date registered

Date prepared

Type

Description/No

Amount

Sequence

Beneficiary

1

07/11/2013

04/07/2006

Mortgage

Y6401/06

2,135,751.80 EUR

-

Alpha Bank Limited

2

17/08/2001

09/08/2001

Floating Charge on all Company's Assets

 

200,000.00 CYP

-

Bank of Cyprus Public Company Limited

 

 

 

 

 

Total Number

Total Amount (EUR)

Mortgage

1

2,135,751.80

Floating Charge on all Company's Assets

1

341,720.29

TOTAL CHARGES

2

2,477,472.09

 

 

 

Negatives

 

A check against our revealed that no negative payment incidents against the subject company, such as unpaid invoices, dishonored cheques, utility bills, bankruptcies etc. exist.

 

 

Financial Statement

 

Please note that the latest financial details were not available at the file of the company at the official companies' registry house; as the law provides for all companies. No financial details were available from other public sources.

 

 

Additional Information

 

We contacted the company in question where we talked to the Company’s Accountant, Ms. Elena Louca, who could not release any information regarding the subject and she asked for a written questionnaire in order to take the authorization from company’s director to provide us with all the information we want.

A questionnaire was sent to the subject but until now, we have not received any reply.

Should any additional information becomes available, we will provide you with a revised report.

Please note that the information included in the report was obtained from the Official Companies' Registrar and from desk research.

 

 

Methodology Used For Report Preparation

 

Perform Searches in:

·         The Registrar of Companies and Official Receiver of the Republic of Cyprus.

·         In house databases for Detrimental Information:

·         Bankruptcy and Dissolution procedures.

·         Issuers of Bounced Cheques.

·         Unpaid Bills.

·         Proprietary databases and global subscription sites.

·         Global and local media.

·         Internet social networks.

·         Relationship/Directorship Search through Local Database.

·         Other local databases as deemed appropriate.

 

Conduct Interviews with:

·         Official(s) / correspondent(s) of the company under review.

·         Supplier(s) or other associated entities of the company.

·         Other local resources with extensive knowledge of the market.

 

Analysis

·         Process and analyse all information gathered.

·         Perform a thorough quality check of the report prior to sending it to the client.

 

Contact Information

 

Name:

Ms. Elena Louca

Position:

Company’s Accountant

 

 

Couldn't supply

Any info

A questionnaire was sent - no reply received

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.13

UK Pound

1

Rs.102.25

Euro

1

Rs.84.72

 

 

INFORMATION DETAILS

 

Report Prepared by :

NNA

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.